VAISHALI8.59

Vaishali Pharma Limited

· Unclassified
₹ CrorePeersTEMBOTOTALOSWALSEEDSGROBTEABEARDSELLHINDCONCROWNARTNIRMANMcap ₹56 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Non-current Assets
+ Property, Plant & Equipment1.51.20.90.9
+ Other Intangibles0.70.80.8
+ Intangibles under Development0.70.20.2
+ Non-current Investments5.65.6
+ Other Non-current Financial Assets1.91.92.02.0
Non-current Financial Assets2.32.47.67.6
+ Deferred Tax Assets0.20.2
+ Other Non-current Assets0.70.70.70.7
Total Non-current Assets5.45.410.410.4
Current Assets
+ Inventories4.83.43.4
+ Trade Receivables49.446.750.850.8
+ Cash & Cash Equivalents1.51.71.11.1
+ Other Bank Balances0.10.10.30.3
+ Other Current Financial Assets12.028.332.132.1
Current Financial Assets63.076.884.384.3
+ Other Current Assets11.022.824.924.9
Total Current Assets74.5104.5113.0113.0
Total Assets80.0109.8123.4123.4
Equity
+ Equity Share Capital10.726.126.126.1
+ Other Equity / Reserves32.138.843.043.0
Equity — Owners of Parent42.864.969.169.1
Total Equity42.864.969.169.1
Liabilities
+ Borrowings — Non-current3.64.25.75.7
Non-current Financial Liabilities3.64.25.75.7
+ Provisions — Non-current0.20.30.30.3
Non-current Liabilities4.04.96.06.0
+ Borrowings — Current9.07.512.812.8
+ Trade Payables19.421.221.2
+ Other Current Financial Liab0.30.30.60.6
Current Financial Liabilities28.734.634.6
+ Provisions — Current0.00.30.3
+ Other Current Liabilities3.74.913.413.4
Current Liabilities33.140.148.348.3
Total Liabilities37.144.954.354.3
Total Equity & Liabilities80.0109.8123.4123.4
Assets — additional as-filed lines
+ Current Tax Assets0.30.3
Trade Payables — MSME split
+ Dues to Micro & Small — Current2.72.7
+ Dues to Other Creditors — Current18.518.5
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.